Oncternal Therapeutics, Inc. (ONCT) CEO Jim Breitmeyer on Q4 2020 Results - Earnings Call Transcript

Oncternal Therapeutics, Inc. (ONCT) CEO Jim Breitmeyer on Q4 2020 Results - Earnings Call Transcript

SeekingAlpha

Published